Next Article in Journal
The Ser290Asn and Thr715Pro Polymorphisms of the SELP Gene Are Associated with A Lower Risk of Developing Acute Coronary Syndrome and Low Soluble P-Selectin Levels in A Mexican Population
Previous Article in Journal
How A Novel Scientific Concept Was Coined the “Molten Globule State”
Previous Article in Special Issue
The Role of Reactive Oxygen Species in Arsenic Toxicity
Open AccessReview

Electrophiles Against (Skin) Diseases: More Than Nrf2

Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH-8091 Zurich, Switzerland
Faculty of Medicine, University of Zurich, Zurich, Switzerland
Author to whom correspondence should be addressed.
Biomolecules 2020, 10(2), 271;
Received: 18 December 2019 / Revised: 4 February 2020 / Accepted: 6 February 2020 / Published: 11 February 2020
The skin represents an indispensable barrier between the organism and the environment and is the first line of defense against exogenous insults. The transcription factor NRF2 is a central regulator of cytoprotection and stress resistance. NRF2 is activated in response to oxidative stress by reactive oxygen species (ROS) and electrophiles. These electrophiles oxidize specific cysteine residues of the NRF2 inhibitor KEAP1, leading to KEAP1 inactivation and, subsequently, NRF2 activation. As oxidative stress is associated with inflammation, the NRF2 pathway plays important roles in the pathogenesis of common inflammatory diseases and cancer in many tissues and organs, including the skin. The electrophile and NRF2 activator dimethyl fumarate (DMF) is an established and efficient drug for patients suffering from the common inflammatory skin disease psoriasis and the neuro-inflammatory disease multiple sclerosis (MS). In this review, we discuss possible molecular mechanisms underlying the therapeutic activity of DMF and other NRF2 activators. Recent evidence suggests that electrophiles not only activate NRF2, but also target other inflammation-associated pathways including the transcription factor NF-κB and the multi-protein complexes termed inflammasomes. Inflammasomes are central regulators of inflammation and are involved in many inflammatory conditions. Most importantly, the NRF2 and inflammasome pathways are connected at different levels, mainly antagonistically.
Keywords: NRF2; skin; inflammation; inflammasomes; electrophile; DMF; NF-κB NRF2; skin; inflammation; inflammasomes; electrophile; DMF; NF-κB
MDPI and ACS Style

Hennig, P.; Fenini, G.; Di Filippo, M.; Beer, H.-D. Electrophiles Against (Skin) Diseases: More Than Nrf2. Biomolecules 2020, 10, 271.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop